The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn's disease

被引：0
|
作者：
Kantasiripitak, W.
Mathot, R.
Oldenburg, B.
Buisson, A.
Ferrante, M.
Laharie, D.
D'Haens, C.
Vermeire, S.
Dreesen, E.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.620
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P497
引用
收藏
页码：S481 / S482
页数：3
相关论文
共 50 条
  • [1] THE VALUE OF COMBINED SERUM INFLIXIMAB AND ENDOSCOPIC HEALING INDEX MONITORING FOR GUIDING INFLIXIMAB DOSING IN PATIENTS WITH CROHN'S DISEASE
    Kantasiripitak, Wannee
    Mathot, Ron
    Dervieux, Thierry
    Jain, Anjali
    Ferrante, Marc
    Laharie, David
    D'Haens, Geert R.
    Vermeire, Severine
    Dreesen, Erwin
    GASTROENTEROLOGY, 2021, 160 (06) : S690 - S690
  • [2] Endoscopic Monitoring of Infliximab Therapy in Crohn's Disease
    af Bjorkesten, Clas-Goran
    Nieminen, Urpo
    Turunen, Ulla
    Arkkila, Perttu E.
    Sipponen, Taina
    Farkkila, Martti A.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (04) : 947 - 953
  • [3] Use of the Endoscopic Healing Index for Monitoring of Disease Activity in Patients With Crohn's Disease in the COVID Era
    Abreu, Maria T.
    Okada, Lauren
    Dervieux, Thierry
    Luo, Allison
    Jain, Anjali
    Ritter, Timothy
    Hanauer, Stephen B.
    CROHNS & COLITIS 360, 2020, 2 (02)
  • [4] The Endoscopic Healing Index in Crohn's Disease: A Serum Proteomic Biomarker for Monitoring Disease Activity
    Noor, Nurulamin M.
    Lee, James C.
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (04) : 669 - 671
  • [5] Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
    Dreesen, Erwin
    Baert, Filip
    Laharie, David
    Bossuyt, Peter
    Bouhnik, Yoram
    Buisson, Anthony
    Lambrecht, Guy
    Louis, Edouard
    Oldenburg, Bas
    Pariente, Benjamin
    Pierik, Marieke
    van der Woude, C. Janneke
    D'Haens, Geert
    Vermeire, Severine
    Gils, Ann
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 637 - +
  • [6] Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn's disease receiving maintenance infliximab: A randomized controlled trial
    Kang, B.
    Moon, J. S.
    Lee, Y. J.
    Kim, M. J.
    Choe, B. H.
    Ko, J. S.
    Park, J. H.
    Choe, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I159 - I159
  • [7] Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn's disease
    Choi, So Yoon
    Kwon, Yiyoung
    Choi, Sujin
    Lee, So Mi
    Choe, Byung-Ho
    Kang, Ben
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] MAINTENANCE INFLIXIMAB DOSING AND ADMINISTRATION PATTERNS IN PATIENTS WITH CROHN'S DISEASE
    Bailey, R.
    Waters, H.
    Ernst, F. R.
    Johnson, B.
    McKenzie, R. S.
    VALUE IN HEALTH, 2010, 13 (03) : A216 - A216
  • [9] Infliximab for Early Endoscopic Recurrence in Patients with Crohn’s Disease
    Takayuki Yamamoto
    Digestive Diseases and Sciences, 2012, 57 : 1724 - 1724
  • [10] Infliximab for Early Endoscopic Recurrence in Patients with Crohn's Disease
    Yamamoto, Takayuki
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (06) : 1724 - 1724
12345